InvestorsHub Logo
Followers 0
Posts 4
Boards Moderated 0
Alias Born 06/11/2019

Re: None

Tuesday, 06/11/2019 11:07:32 AM

Tuesday, June 11, 2019 11:07:32 AM

Post# of 2432
New to this board, but certainly not new to this stock. Been in it for what seems like forever and own a substantial number of shares.

The main thing holding the stock back--other than having been delisted--appears to be the company awaiting FDA approval for its VBX-100 drug application. Without FDA approval, they can't move forward with clinical trials. Though I wouldn't be surprised to learn there has been some quiet movement on that front in Canada.

It would certainly be nice to see: (1) the company regain its listing on a tradeable exchange, but that's not going to happen until the stock price recovers substantially...and that's not going to happen until there is substantive news; (2) FDA approval for its VBX-100 application; (3) Approval for some/all of the 79 patents applied for on more than 200 different compounds.

Though I've always liked previous management, they were never able to execute and gain any footing. I am optimistic this new leadership team can get something going once some of the needed approvals come through. Meanwhile we wait.

Hope springs eternal!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RNGE News